A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Novavax Inc stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 92,101 shares of NVAX stock, worth $780,095. This represents 0.0% of its overall portfolio holdings.

Number of Shares
92,101
Previous 66,804 37.87%
Holding current value
$780,095
Previous $845,000 37.63%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$10.71 - $17.11 $270,930 - $432,831
25,297 Added 37.87%
92,101 $1.16 Million
Q2 2024

Aug 14, 2024

BUY
$3.89 - $20.97 $259,867 - $1.4 Million
66,804 New
66,804 $845,000

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $662M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Mirae Asset Global Etfs Holdings Ltd. Portfolio

Follow Mirae Asset Global Etfs Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Etfs Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Etfs Holdings Ltd. with notifications on news.